Cargando…
Cutaneous neurofibromas in the genomics era: current understanding and open questions
Cutaneous neurofibromas (cNF) are a nearly ubiquitous symptom of neurofibromatosis type 1 (NF1), a disorder with a broad phenotypic spectrum caused by germline mutation of the neurofibromatosis type 1 tumour suppressor gene (NF1). Symptoms of NF1 can include learning disabilities, bone abnormalities...
Autores principales: | Allaway, Robert J., Gosline, Sara J. C., La Rosa, Salvatore, Knight, Pamela, Bakker, Annette, Guinney, Justin, Le, Lu Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008439/ https://www.ncbi.nlm.nih.gov/pubmed/29695767 http://dx.doi.org/10.1038/s41416-018-0073-2 |
Ejemplares similares
-
A high-throughput molecular data resource for cutaneous neurofibromas
por: Gosline, Sara J.C., et al.
Publicado: (2017) -
Probing the chemical–biological relationship space with the Drug Target Explorer
por: Allaway, Robert J., et al.
Publicado: (2018) -
Engaging a community to enable disease-centric data sharing with the NF Data Portal
por: Allaway, Robert J., et al.
Publicado: (2019) -
The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin
por: Rice, Frank L., et al.
Publicado: (2019) -
Management of cutaneous neurofibroma: current therapy and future directions
por: Chamseddin, Bahir H, et al.
Publicado: (2019)